There are four models of South Korea Aozitai planting system, namely GS series, SS series, TS series and US series.
Among them, there are conical implants suitable for Class II and III and short implants suitable for the upper and lower posterior tooth areas* Recently, its new product TSIII CA hydrophilic implant has also been launched.

What is hydrophilic implant?
In general, hydrophilic implants can optimize the osseointegration process to a certain extent, such as promoting the adhesion, proliferation and differentiation of bone cells, thus improving the biological stability of early implantation.
The osseointegration time of conventional implants is shortened to about 4-8 weeks, which not only improves the efficiency but also improves the stability.
What are the characteristics of Aozitai TSIII CA hydrophilic implant series?
The TSIII CA hydrophilic implant is mainly an aqueous solution (CaCl2) to enhance the activation energy of the surface, and also to enhance the adsorption of blood cells and the initial bone bonding performance, The period of planting and repairing is relatively short.
Next, look at the characteristics of OSSTEM hydrophilic implants in detail.
(Warm tip - the following information is the demonstration of Aozitai brand in a specific laboratory)

(Instant blood immersion) Compared with hydrophobic implants, the wettability of blood cells on the surface of implants was improved.

(After soaking for 20 minutes) Compared with ordinary implants, TSIII CA blood clots have rapidly formed on the surface of implants.

(Enlarged display after blood cell attachment) Compared with hydrophobic implant surface, the red blood cells and fiber cells were also significantly different.

(Comparison of mandibular defects in miniature pigs) Four weeks later, good bone tissue was formed on the surface of Aozitai hydrophilic implant.
From the above experimental tests, it can be seen that compared with hydrophobic implants, the new product of Aozitai - hydrophilic implants have advantages in early osseointegration.